bioMérieux provides a wide range of manual and automated products to ensure that aseptic conditions have been maintained during processing. For sterile manufacturing, bioMérieux provides solutions for in-process microbial detection and final sterility testing, allowing companies to follow either PAT or pharmacopoeia compendial methods. From surface and personnel monitoring to air sampling, microbial detection and microbial limits testing, bioMérieux helps the pharmaceutical, biotech and advanced medicines industries manage microbiological risks.
The BacT/ALERT 3D Dual T system is part of our solutions range and provides a rapid alternative to the compendial sterility test and can be used for in-process control and final product testing. An automated method providing non-destructive, continuous monitoring and objective reading, BacT/ALERT 3D Dual T provides a solution for  the sterility testing of short-shelf life, turbid products common to the advanced medicines sector enabling sites to adhere to GMP requirements. BacT/ALERT 3D is already in routine use in autologous cell therapy, tissue and cord bank, vaccine manufacturing  and cell culture scale-up sites in the UK and Ireland and around the world.
Visit our exhibition stand, (level 1, outside conference room 1) and discover bioMérieux’s complete range of solutions for managing the microbiological risks in advanced therapies and regenerative medicines.


World Advanced Therapies & Regenerative Medicine Congress


Erica Baeta
+44 (0)207 092 1152


Jessica Robinson
t/ +44 (0)207 092 1150


Issa Mauthoor
+44 (0)207 092 1257